MRONJ risk of adjuvant bisphosphonates in early stage breast cancer

被引：0

作者：

V. Patel

J. Mansi

S. Ghosh

J. Kwok

M. Burke

D. Reilly

N. Nizarali

C. Sproat

K. Chia

机构：

[1] Dept of Oral Surgery,Department of Oncology

[2] Guys & St Thomas' NHS Foundation Trust,undefined

[3] Fl 23,undefined

[4] Tower Wing,undefined

[5] Great Maze Pond,undefined

[6] London,undefined

[7] SE1 9RT,undefined

[8] Guys & St Thomas' NHS Foundation Trust,undefined

[9] Fl 23,undefined

[10] Tower Wing,undefined

[11] Great Maze Pond,undefined

[12] London,undefined

[13] SE1 9RT,undefined

[14] Sedation and Special Care,undefined

[15] Guys & St Thomas' NHS Foundation Trust,undefined

[16] Fl 23,undefined

[17] Tower Wing,undefined

[18] Great Maze Pond,undefined

[19] London,undefined

[20] SE1 9RT,undefined

来源：

British Dental Journal | 2018年 / 224卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Highlights that bisphosphonates continue to be the most common drug implicated in medication-related osteonecrosis of the jaw.Shows that an additional use of bisphosphonates has been indicated and now a further 20,000 women may be prescribed the medication and be exposed to the risk of jaw necrosis.Suggests the burden of additional dental assessment for these patients will fall upon GDPs.Introduces a new communication idea of the dental alert card which provides a warning to dentists for 'at risk' patients.

引用

下载

页码：74 / 79

页数：5

共 50 条

[1] MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
Patel, V.
Mansi, J.
Ghosh, S.
Kwok, J.
Burke, M.
Reilly, D.
Nizarali, N.
Sproat, C.
Chia, K.
BRITISH DENTAL JOURNAL, 2018, 224 (02) : 74 - 79
[2] Adjuvant bisphosphonates for early-stage breast cancer
Brufsky, Adam
LANCET ONCOLOGY, 2011, 12 (07): : 610 - 611
[3] Bisphosphonates in the adjuvant treatment of early breast cancer
Gnant, M.
BREAST CANCER RESEARCH, 2009, 11 : S7 - S7
[4] Bisphosphonates in the adjuvant treatment of early breast cancer
M Gnant
Breast Cancer Research, 11
[5] Adjuvant therapy for early stage breast cancer
Sledge, GW
SEMINARS IN ONCOLOGY, 1996, 23 (01) : 51 - 54
[6] Adjuvant Bisphosphonates and Breast Cancer Survival
Strobl, Stephanie
Korkmaz, Belgin
Devyatko, Yelena
Schuetz, Michael
Exner, Ruth
Dubsky, Peter C.
Jakesz, Raimund
Gnant, Michael
ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 1 - 10
[7] Bisphosphonates as adjuvant therapy for breast cancer
Burkinshaw, Roger
Coleman, Robert
WOMENS HEALTH, 2006, 2 (01) : 115 - 126
[8] Bisphosphonates as adjuvant therapy for breast cancer
Gnant M.
Dubsky P.
Fitzal F.
Bachleitner-Hofmann T.
Exner R.
Blaha P.
Jakesz R.
Schippinger W.
Greil R.
Current Breast Cancer Reports, 2009, 1 (1) : 54 - 63
[9] Bisphosphonates in the Adjuvant Treatment of Breast Cancer
Winter, M. C.
Coleman, R. E.
CLINICAL ONCOLOGY, 2013, 25 (02) : 135 - 145
[10] Bisphosphonates in Adjuvant Therapy of Breast Cancer
Deuber, Heinz Juergen
Theiss, Friedrich
MEDIZINISCHE KLINIK, 2010, 105 (09) : 635 - 646

← 1 2 3 4 5 →